Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Konen

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cornea|August 6, 2000
Intracorneal inclusion of high-molecular-weight sodium hyaluronate following detachment of Descemet's membrane during viscocanalostomyC Lüke, T Dietlein, P Jacobi, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1985
[Risk factors and organic changes in patients with arterial and venous retinal circulation disorders]R Brunner, A Heinen, W Konen, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 1, 1995
[Intraocular silicone lenses and silicone oil]K U Bartz-Schmidt, W Konen, P Esser, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1984
[Changes in hemorheologic and physiologic coagulation parameters in different methods of therapy of retinal vascular disorders--a randomized double-blind study]A Heinen, R Brunner, V Hossmann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1992
Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric studyM Diestelhorst, F Aspacher, W Konen, et al.
European Journal of Clinical Pharmacology|January 1, 1975
Bioavailability of m-octopamine in man related to its metabolismJ H Hengstmann, W Konen, C Konen, et al.
Acta Medica Austriaca|January 1, 1991
Erythrocyte apheresis in combination with elimination of fibrinogen and plasma proteins of higher molecular weight in macular disease and in uveal effusion syndromeR Brunner, H Borberg, J Kadar, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1974
The physiological disposition of p-octopamine in manJ H Hengstmann, W Konen, C Konen, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1986
[Individual therapy of problem patients with chronic retinal and chorioretinal circulatory disorders of various origins]R Brunner, A Heinen, W Sickel, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 1, 1992
[Effect of 0.1% dexamethasone and 1.0% prednisolone acetate eyedrops on the blood-aqueous humor barrier]M Diestelhorst, F Aspacher, W Konen, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cornea|August 6, 2000
Intracorneal inclusion of high-molecular-weight sodium hyaluronate following detachment of Descemet's membrane during viscocanalostomyC Lüke, T Dietlein, P Jacobi, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1985
[Risk factors and organic changes in patients with arterial and venous retinal circulation disorders]R Brunner, A Heinen, W Konen, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 1, 1995
[Intraocular silicone lenses and silicone oil]K U Bartz-Schmidt, W Konen, P Esser, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1984
[Changes in hemorheologic and physiologic coagulation parameters in different methods of therapy of retinal vascular disorders--a randomized double-blind study]A Heinen, R Brunner, V Hossmann, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1992
Effect of dexamethasone 0.1% and prednisolone acetate 1.0% eye drops on the blood-aqueous barrier after cataract surgery: a controlled randomized fluorophotometric studyM Diestelhorst, F Aspacher, W Konen, et al.
European Journal of Clinical Pharmacology|January 1, 1975
Bioavailability of m-octopamine in man related to its metabolismJ H Hengstmann, W Konen, C Konen, et al.
Acta Medica Austriaca|January 1, 1991
Erythrocyte apheresis in combination with elimination of fibrinogen and plasma proteins of higher molecular weight in macular disease and in uveal effusion syndromeR Brunner, H Borberg, J Kadar, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 27, 1974
The physiological disposition of p-octopamine in manJ H Hengstmann, W Konen, C Konen, et al.
Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1986
[Individual therapy of problem patients with chronic retinal and chorioretinal circulatory disorders of various origins]R Brunner, A Heinen, W Sickel, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 1, 1992
[Effect of 0.1% dexamethasone and 1.0% prednisolone acetate eyedrops on the blood-aqueous humor barrier]M Diestelhorst, F Aspacher, W Konen, et al.
Pageof 7